Trial reportBMC public health2017
Effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: a randomized controlled trial.
Trial report in BMC public health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02123329 (Assessing the Effectiveness of a Pharmacist-delivered Smoking Cessation Program in the State of Qatar), which is not on this map. Cited by 23 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Assessing the Effectiveness of a Pharmacist-delivered Smoking Cessation Program in the State of Qatar
Who cites it
23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 47 citations in OpenAlex.
- IntensiveEuropean respiratory review : an official journal of the European Respiratory Society · 2022Pooled it
- Promoting Community Pharmacy Practice for Chronic Obstructive Pulmonary Disease (COPD) Management: A Systematic Review and Logic Model.International journal of chronic obstructive pulmonary disease · 2020Pooled it
- Community pharmacy personnel interventions for smoking cessation.The Cochrane database of systematic reviews · 2019Pooled it
- A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial.PloS one · 2022Trial
- Impact of Pharmacist-Led Interventions on Patient Outcomes in Gulf Cooperation Council Countries: A Systematic Review and Meta-Analysis.Pharmacy (Basel, Switzerland) · 2026Review
- Digital-Assisted Community Pharmacy Cessation for Dual-Tobacco Users in Jordan: A Hybrid Cluster Randomized Controlled Trial.Pharmacy (Basel, Switzerland) · 2026Article
- Knowledge, attitudes, and practices of community pharmacists on pharmacological approaches to smoking cessation in Saudi Arabia.BMC health services research · 2025Article
- Comparison of quit rates among exclusive cigarette smokers at Tobacco Control Center in Qatar: telephone versus face-to-face consultation.BMC primary care · 2025Article
- Barriers to smoking interventions in community healthcare settings: a scoping review.Health promotion international · 2024Article
- Systematic literature review of the impact of psychiatric pharmacists.The mental health clinician · 2024Review
- Evaluation of pharmaceutical care services in the Middle East Countries: a review of studies of 2013-2020.BMC public health · 2023Review
- Feasibility and Acceptability of a Telephone-Based Smoking Cessation Intervention for Qatari Residents.International journal of environmental research and public health · 2022Article
- Effectiveness and cost-effectiveness of an intensive and abbreviated individualized smoking cessation program delivered by pharmacists: A pragmatic, mixed-method, randomized trial.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC · 2022Article
- The role of community pharmacists in depression management: a survey of attitudes, practices and perceived barriers.International journal of clinical pharmacy · 2022Article
- Article
- Tobacco cessation programs and factors associated with their effectiveness in the Middle East: A systematic review.Tobacco induced diseases · 2022Review
- A Telephone-Based Tobacco Cessation Program in the State of Qatar: Protocol of a Feasibility Study.International journal of environmental research and public health · 2021Article
- A Pragmatic Pilot Cluster-Randomized Study of Tobacco Screening and Smoking Cessation Program for Community Pharmacies in Japan: FINE Program.Journal of smoking cessation · 2021Article
- Factors associated with smoking cessation and smoking cessation interventions in the Gulf Cooperation Council countries.Saudi medical journal · 2019Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCigarette smoking is one of the major preventable causes of death and diseases in Qatar. The study objective was to test the effect of a structured smoking cessation program delivered by trained pharmacists on smoking cessation rates in Qatar.
methodsA prospective randomized controlled trial was conducted in eight ambulatory pharmacies in Qatar. Eligible participants were smokers 18 years and older who smoked one or more cigarettes daily for 7 days, were motivated to quit, able to communicate in Arabic or English, and attend the program sessions. Intervention group participants met with the pharmacists four times at 2 to 4 week intervals. Participants in the control group received unstructured brief smoking cessation counseling. The primary study outcome was self-reported continuous abstinence at 12 months. Analysis was made utilizing data from only those who responded and also using intent-to-treat principle. A multinomial logistic regression model was fitted to assess the predictors of smoking at 12 months. Analysis was conducted using IBM-SPSS® version 23 and STATA® version 12.
resultsA total of 314 smokers were randomized into two groups: intervention (n = 167) and control (n = 147). Smoking cessation rates were higher in the intervention group at 12 months; however this difference was not statistically significant (23.9% vs. 16.9% p = 0.257). Similar results were observed but with smaller differences in the intent to treat analysis (12.6% vs. 9.5%, p = 0.391). Nevertheless, the daily number of cigarettes smoked for those who relapsed was significantly lower (by 4.7 and 5.6 cigarettes at 3 and 6 months respectively) in the intervention group as compared to the control group (p = 0.041 and p = 0.018 respectively). At 12 months, the difference was 3.2 cigarettes in favor of the intervention group but was not statistically significant (p = 0.246). Years of smoking and daily number of cigarettes were the only predictors of smoking as opposed to quitting at 12 months (p = 0.005; p = 0.027 respectively).
conclusionsThere was no statistically significant difference in the smoking cessation rate at 12 months between the groups. However, the smoking cessation program led to higher (albeit non-significant) smoking cessation rates compared with usual care. More research should be conducted to identify factors that might improve abstinence.
trial registrationClinical Trials NCT02123329 . Registration date 20 April 2014.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.